Filing Details
- Accession Number:
- 0001181431-14-027420
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-07-25 17:51:43
- Reporting Period:
- 2014-07-23
- Filing Date:
- 2014-07-25
- Accepted Time:
- 2014-07-25 17:51:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1560782 | M James Daly | Experimental Station Route 141 And Henry Clay Rd Wilmington DE 19880 | Evp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-07-23 | 2,778 | $18.32 | 2,778 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-07-23 | 7,832 | $16.62 | 10,610 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-07-23 | 501 | $16.62 | 11,111 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-07-23 | 11,111 | $48.54 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-07-23 | 2,778 | $0.00 | 2,778 | $18.32 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-07-23 | 7,832 | $0.00 | 7,832 | $16.62 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-07-23 | 501 | $0.00 | 501 | $16.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 47,231 | 2020-02-08 | No | 4 | M | Direct | |
| 116,479 | 2019-10-21 | No | 4 | M | Direct | |
| 8,523 | 2019-10-21 | No | 4 | M | Direct |
Footnotes
- Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Beginning October 22, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Represents weighted average sale price. Actual sales prices ranged from $48.17-$48.77.
Billionaire Hedge Funds
